Saturday, November 28, 2015 12:48:20 PM
Not only could they receive more volume for this stock, they could also get some assets (cash/shares) for the rights, which they have not been receiving from SFMI... Thats a much smarter plan than watching PQ twiddle his thumbs and drag everyone down with the ship.
The WEM property is only good for a pump and dump now and they wont get that without a massive restructuring of SFMI, which takes time/money and will wipe all of the current SFMI holders out anyways (current SFMI shareholders lose no matter what happens)... and im sure it would be easy to take the rights back due to SFMI not living up to their commitments. In fact, SFMI doesn't even have a PLAN for any future developments.
Add this to their other plans to pump this ticker and there could be some nice gains to be made here... but it has to start happening NOW, so its ready for next year, when IMO the precious metals market sees some action/interest, due to election year uncertainties.
Ya cant plan this stuff last minute, when metals are already active, you have to start getting it ready NOW.
My postings contain many opinions. So please do your own research
and validation.
Recent BRVO News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:36:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2024 08:24:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:12:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:36:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:15:48 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:31:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 12:27:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/28/2023 08:11:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:02:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:03:17 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM